The ABBV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABBV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ABBV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ABBV Detailed Price Forecast - CNN Money||View ABBV Detailed Summary - Google Finance|
|View ABBV Detailed Summary - Yahoo! Finance||View ABBV Stock Research & Analysis - Zacks.com|
|View ABBV Trends & Analysis - Trade-Ideas||View ABBV Major Holders - Barrons|
|View ABBV Call Transcripts - NASDAQ||View ABBV Breaking News & Analysis - Seeking Alpha|
|View ABBV Annual Report - CompanySpotlight.com||View ABBV OTC Short Report - OTCShortReport.com|
|View ABBV Fundamentals - TradeKing||View ABBV SEC Filings - Bar Chart|
|View Historical Prices for ABBV - The WSJ||View Performance/Total Return for ABBV - Morningstar|
|View the Analyst Estimates for ABBV - MarketWatch||View the Earnings History for ABBV - CNBC|
|View the ABBV Earnings - StockMarketWatch||View ABBV Buy or Sell Recommendations - MacroAxis|
|View the ABBV Bullish Patterns - American Bulls||View ABBV Short Pain Metrics - ShortPainBot.com|
|View ABBV Stock Mentions - StockTwits||View ABBV Stock Mentions - PennyStockTweets|
|View ABBV Stock Mentions - Twitter||View ABBV Investment Forum News - Investor Hub|
|View ABBV Stock Mentions - Yahoo! Message Board||View ABBV Stock Mentions - Seeking Alpha|
|View Insider Transactions for ABBV - SECform4.com||View Insider Transactions for ABBV - Insider Cow|
|View ABBV Major Holdings Summary - CNBC||View Insider Disclosure for ABBV - OTC Markets|
|View Insider Transactions for ABBV - Yahoo! Finance||View Institutional Holdings for ABBV - NASDAQ|
|View ABBV Stock Insight & Charts - FinViz.com||View ABBV Investment Charts - StockCharts.com|
|View ABBV Stock Overview & Charts - BarChart||View ABBV User Generated Charts - Trading View|
NEW YORK, Aug. 19, 2018-- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...
3 Growth Stocks for Successful Investors
Posted on Friday August 17, 2018
It's not always easy to find success in the market, but there are good reasons these three stocks look like winners.
Here’s What Tesaro’s Valuation Trend Indicates
Posted on Thursday August 16, 2018
Tesaro’s (TSRO) Phase 3 PRIMA trial of Zejula to evaluate it for the treatment of women with newly diagnosed ovarian cancer, irrespective of BRCA mutation status, has been completely enrolled. Its Phase 2 trial of Zejula in combination with an anti-PD-1 antibody in first-line non-small cell lung cancer is ongoing. The company expects to present data in the first half of 2019. In its immuno-oncology pipeline, Tesaro plans to submit a BLA (Biologic License Application) for TSR-042 in 2019.
Analysts’ Expectations for Tesaro and Its Peers in August
Posted on Thursday August 16, 2018
Tesaro (TSRO) is a commercial-stage biopharmaceutical company primarily focused on developing treatments for solid tumors by using small molecules and immune-oncology antibodies both as monotherapies and in combinations. Tesaro’s key product, Zejula, has been approved in the United States as well as the European Union as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Tesaro commercialized Zejula in the United States in April 2017 and in Europe in December 2017.